Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -0.06x is 100% above its 2-year average of -435.06x, near the high end of its 2-year range (-2630.21x–-0.06x).
As of the fiscal period ended Friday, December 31, 2021. 99.99% above its 12-month average of -685.01x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2021 (2021-12-31): -0.06x.
INTEREST COVERAGE RATIO
-0.06x
INTEREST COVERAGE RATIO AVG TTM
-685.01x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+99.99%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.84x
median of 382 covered companies
CURRENT VS SECTOR MEDIAN
+98.84%
vs the sector median at left
Dermata Therapeutics, Inc.
Market Cap
$4.55M
Interest Coverage Ratio
-0.06x
TTM Avg
-685.01x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.43M
Interest Coverage Ratio
-765.53x
TTM Avg
1.76x
3Y Avg
1.76x
5Y Avg
1.76x
Market Cap
$4.63M
Interest Coverage Ratio
-16.26x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.28M
Interest Coverage Ratio
-21.32x
TTM Avg
128.62x
3Y Avg
128.62x
5Y Avg
128.62x
Market Cap
$4.73M
Interest Coverage Ratio
N/A
TTM Avg
1.10x
3Y Avg
1.10x
5Y Avg
1.10x
Market Cap
$4.83M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.00M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.08M
Interest Coverage Ratio
-345.15x
TTM Avg
1.19x
3Y Avg
1.19x
5Y Avg
1.19x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | $4.55M | -0.06x | -685.01x | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.43M | -765.53x | 1.76x | 1.76x | 1.76x |
| CalciMedica, Inc. (CALC)vs › | $4.63M | -16.26x | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.28M | -21.32x | 128.62x | 128.62x | 128.62x |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.73M | N/A | 1.10x | 1.10x | 1.10x |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.83M | N/A | N/A | N/A | N/A |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A | N/A | N/A | N/A |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.00M | N/A | N/A | N/A | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.08M | -345.15x | 1.19x | 1.19x | 1.19x |
| Imunon, Inc. (IMNN)vs › | $5.11M | N/A | 1.00x | 1.02x | 1.02x |
Interest Coverage
-0.1x
Debt/Equity
0.00
Current Ratio
2.81
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-12-31 | -0.06x |
| 2021-09-30 | -2630.21x |
| 2021-06-30 | -729.55x |
| 2021-03-31 | -52.44x |
| 2020-12-31 | -12.77x |
| 2020-09-30 | -9.42x |
| 2020-06-30 | -27.47x |
| 2020-03-31 | -18.58x |
